Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec 3;8:478. doi: 10.1038/s41420-022-01259-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 1 — A The establishment procedure of Trastuzumab acquired resistant PDX model. The mice of 176P were exposed to Trastuzumab at the dose of 20 mg/kg for about 9 months (5 passages) to obtain the resistant model 176R. B Tumor growth curve of the last passage when the model was established. C HER2 expression before and after Trastuzumab resistance identified by immunohistochemistry (x200 for the upper row, x1000 for the lower row). D HER2 expression before and after Trastuzumab resistance identified by western blot. E H&E (x200) and Ki67 (x200) staining showed the Lauren classification, histological differentiation, and cell proliferation (176P > 90%, 176t < 10%, 176R > 90%), respectively. F Pearson correlation coefficient (presented by R² value) of samples by RNA-seq confirmed the tissue homology before and after Trastuzumab resistance.